Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Investigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice.

Amran MY, Fujii J, Suzuki SO, Kolling GL, Villanueva SY, Kainuma M, Kobayashi H, Kameyama H, Yoshida S.

PLoS One. 2013;8(3):e58959. doi: 10.1371/journal.pone.0058959. Epub 2013 Mar 13.

2.

Proposal for effective treatment of Shiga toxin-producing Escherichia coli infection in mice.

Amran MY, Fujii J, Kolling GL, Villanueva SY, Kainuma M, Kobayashi H, Kameyama H, Yoshida S.

Microb Pathog. 2013 Dec;65:57-62. doi: 10.1016/j.micpath.2013.09.008. Epub 2013 Oct 10.

PMID:
24120399
3.

Virulence of the Shiga toxin type 2-expressing Escherichia coli O104:H4 German outbreak isolate in two animal models.

Zangari T, Melton-Celsa AR, Panda A, Boisen N, Smith MA, Tatarov I, De Tolla LJ, Nataro JP, O'Brien AD.

Infect Immun. 2013 May;81(5):1562-74. doi: 10.1128/IAI.01310-12. Epub 2013 Feb 25.

4.

Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4.

Nitschke M, Sayk F, Härtel C, Roseland RT, Hauswaldt S, Steinhoff J, Fellermann K, Derad I, Wellhöner P, Büning J, Tiemer B, Katalinic A, Rupp J, Lehnert H, Solbach W, Knobloch JK.

JAMA. 2012 Mar 14;307(10):1046-52. doi: 10.1001/jama.2012.264.

PMID:
22416100
5.

Shiga toxin-producing Escherichia coli O104:H4: a new challenge for microbiology.

Muniesa M, Hammerl JA, Hertwig S, Appel B, Brüssow H.

Appl Environ Microbiol. 2012 Jun;78(12):4065-73. doi: 10.1128/AEM.00217-12. Epub 2012 Apr 13. Review.

6.

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.

Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Müller L, King LA, Rosner B, Buchholz U, Stark K, Krause G; HUS Investigation Team.

N Engl J Med. 2011 Nov 10;365(19):1771-80. doi: 10.1056/NEJMoa1106483. Epub 2011 Jun 22.

7.

The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak.

Magnus T, Röther J, Simova O, Meier-Cillien M, Repenthin J, Möller F, Gbadamosi J, Panzer U, Wengenroth M, Hagel C, Kluge S, Stahl RK, Wegscheider K, Urban P, Eckert B, Glatzel M, Fiehler J, Gerloff C.

Brain. 2012 Jun;135(Pt 6):1850-9. doi: 10.1093/brain/aws090. Epub 2012 Apr 26.

8.
9.

Shiga toxin 1 induces on lipopolysaccharide-treated astrocytes the release of tumor necrosis factor-alpha that alter brain-like endothelium integrity.

Landoni VI, Schierloh P, de Campos Nebel M, Fernández GC, Calatayud C, Lapponi MJ, Isturiz MA.

PLoS Pathog. 2012;8(3):e1002632. doi: 10.1371/journal.ppat.1002632. Epub 2012 Mar 29.

10.

A comparison of Shiga-toxin 2 bacteriophage from classical enterohemorrhagic Escherichia coli serotypes and the German E. coli O104:H4 outbreak strain.

Laing CR, Zhang Y, Gilmour MW, Allen V, Johnson R, Thomas JE, Gannon VP.

PLoS One. 2012;7(5):e37362. doi: 10.1371/journal.pone.0037362. Epub 2012 May 23.

11.

The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome.

Orth D, Grif K, Khan AB, Naim A, Dierich MP, Würzner R.

Diagn Microbiol Infect Dis. 2007 Nov;59(3):235-42. Epub 2007 Oct 10.

PMID:
17931818
12.

Molecular epidemiology of a household outbreak of Shiga-toxin-producing Escherichia coli in Poland due to secondary transmission of STEC O104:H4 from Germany.

Januszkiewicz A, Szych J, Rastawicki W, Wołkowicz T, Chróst A, Leszczyńska B, Kuźma E, Roszkowska-Blaim M, Gierczyński R.

J Med Microbiol. 2012 Apr;61(Pt 4):552-8. doi: 10.1099/jmm.0.039289-0. Epub 2011 Dec 1.

PMID:
22135021
13.

A new health threat in Europe: Shiga toxin-producing Escherichia coli O104:H4 infections.

Wu CJ, Hsueh PR, Ko WC.

J Microbiol Immunol Infect. 2011 Oct;44(5):390-3. doi: 10.1016/j.jmii.2011.07.001. Epub 2011 Sep 8. Review.

14.

Dexamethasone rescues neurovascular unit integrity from cell damage caused by systemic administration of shiga toxin 2 and lipopolysaccharide in mice motor cortex.

Pinto A, Jacobsen M, Geoghegan PA, Cangelosi A, Cejudo ML, Tironi-Farinati C, Goldstein J.

PLoS One. 2013 Jul 23;8(7):e70020. doi: 10.1371/journal.pone.0070020. Print 2013.

15.

Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.

Watanabe M, Matsuoka K, Kita E, Igai K, Higashi N, Miyagawa A, Watanabe T, Yanoshita R, Samejima Y, Terunuma D, Natori Y, Nishikawa K.

J Infect Dis. 2004 Feb 1;189(3):360-8. Epub 2004 Jan 21.

16.

Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology.

Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A, Prior K, Szczepanowski R, Ji Y, Zhang W, McLaughlin SF, Henkhaus JK, Leopold B, Bielaszewska M, Prager R, Brzoska PM, Moore RL, Guenther S, Rothberg JM, Karch H.

PLoS One. 2011;6(7):e22751. doi: 10.1371/journal.pone.0022751. Epub 2011 Jul 20.

17.

Influence of Escherichia coli shiga toxin on the mammalian central nervous system.

Obata F.

Adv Appl Microbiol. 2010;71:1-19. doi: 10.1016/S0065-2164(10)71001-7. Epub 2010 Feb 20. Review.

PMID:
20378049
18.

Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.

Fujii J, Kita T, Yoshida S, Takeda T, Kobayashi H, Tanaka N, Ohsato K, Mizuguchi Y.

Infect Immun. 1994 Aug;62(8):3447-53.

19.

Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009.

Nielsen S, Frank C, Fruth A, Spode A, Prager R, Graff A, Plenge-Bönig A, Loos S, Lütgehetmann M, Kemper MJ, Müller-Wiefel DE, Werber D.

Zoonoses Public Health. 2011 Dec;58(8):567-72. doi: 10.1111/j.1863-2378.2011.01405.x. Epub 2011 Apr 6.

PMID:
21824358
20.

Relationship between pathogenicity for humans and stx genotype in Shiga toxin-producing Escherichia coli serotype O157.

Kawano K, Okada M, Haga T, Maeda K, Goto Y.

Eur J Clin Microbiol Infect Dis. 2008 Mar;27(3):227-32. Epub 2007 Dec 11.

PMID:
18071766
Items per page

Supplemental Content

Write to the Help Desk